TYPHIM VI
NDC 50090-1493, SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN, injection, solution, from A-S Medication Solutions.
- Product NDC
- 50090-1493
- Status
- Listed
- Labeler
- A-S Medication Solutions
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA103936
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50090-1493 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN25 ug/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Inactivated Salmonella Typhi Vaccine [EPC]; Polysaccharides, Bacterial [CS]; Vaccines, Inactivated [CS]; Vaccines, Typhoid [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50090-1493-0 | 50090149300 | 1 SYRINGE in 1 POUCH (50090-1493-0) / .5 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50090-1493 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50090-1493 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50090-1493. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.